Literature DB >> 17310354

[Axillar lymphadenectomy].

D Oertli1.   

Abstract

Axillary dissection aims at local tumor control and staging. Among breast cancer, malignant melanoma and other solid malignancies, the nodal status is still the most important predictive and prognostic factor. Today, because of its morbidity, axillary lymphadenectomy is indicated only when the sentinel lymph node is involved by metastasis after histopathologic investigation. The surgical technique of axillary dissection is presented, complications and oncologic outcomes are summarised after dissection for breast carcinoma and malignant melanoma, respectively.

Entities:  

Mesh:

Year:  2007        PMID: 17310354     DOI: 10.1007/s00104-006-1297-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  52 in total

1.  Patterns of recurrence in patients with melanoma after radical lymph node dissection.

Authors:  Nir Nathansohn; Jacob Schachter; Haim Gutman
Journal:  Arch Surg       Date:  2005-12

2.  Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care.

Authors:  K M McMasters; A E Giuliano; M I Ross; D S Reintgen; K K Hunt; D R Byrd; V S Klimberg; P W Whitworth; L C Tafra; M J Edwards
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245

Review 3.  New biologic prognostic factors in breast cancer.

Authors:  G M Clark; W L McGuire
Journal:  Oncology (Williston Park)       Date:  1989-05       Impact factor: 2.990

Review 4.  [Basic principles and value of lymphadenectomy in breast carcinoma].

Authors:  F W Schildberg; F Löhe
Journal:  Chirurg       Date:  1996-08       Impact factor: 0.955

5.  Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.

Authors:  C Gajdos; P I Tartter; I J Bleiweiss
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

6.  Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.

Authors:  Igor Langer; Walter Richard Marti; Ulrich Guller; Holger Moch; Felix Harder; Daniel Oertli; Markus Zuber
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

7.  Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women.

Authors:  Larissa K F Temple; Roberta Baron; Hiram S Cody; Jane V Fey; Howard T Thaler; Patrick I Borgen; Alexander S Heerdt; Leslie L Montgomery; Jeanne A Petrek; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2002-08       Impact factor: 5.344

8.  Axillary lymph node dissection for T1a breast carcinoma. Is it indicated?

Authors:  M J Silverstein; E D Gierson; J R Waisman; G M Senofsky; W J Colburn; P Gamagami
Journal:  Cancer       Date:  1994-02-01       Impact factor: 6.860

9.  Preservation of muscle fascia to decrease lymphedema after complete axillary and ilioinguinofemoral lymphadenectomy for melanoma.

Authors:  Gary Lawton; Hope Rasque; Stephan Ariyan
Journal:  J Am Coll Surg       Date:  2002-09       Impact factor: 6.113

10.  Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey.

Authors:  M A Warmuth; G Bowen; L R Prosnitz; L Chu; G Broadwater; B Peterson; G Leight; E P Winer
Journal:  Cancer       Date:  1998-10-01       Impact factor: 6.860

View more
  3 in total

1.  Seroma formation after mastectomy: pathogenesis and prevention.

Authors:  Sanjitha Sampathraju; Gabriel Rodrigues
Journal:  Indian J Surg Oncol       Date:  2011-04-02

2.  Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia Secondary to Infected Seroma: A Rare Case Report.

Authors:  Ruhma Ali; Aditya Patel; Ahmed Abbas; Muhammad Hussain; Jihad Slim; Jack Boghossian
Journal:  Cureus       Date:  2022-02-19

Review 3.  Postoperative Fluid Collections in Total Joint Arthroplasty: A Narrative Review.

Authors:  Dylan Smith; Galen Berdis; Vishavpreet Singh; Alexander Caughran; Matthew Bullock
Journal:  Orthop Res Rev       Date:  2022-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.